PEOPLE ON THE MOVE
Pacira Pharmaceuticals
Analgesics expert James Jones has been appointed Chief Medical Officer and senior VP by Pacira Pharmaceuticals.
He will oversee development of the company’s DepoFoam pipeline and Exparel (bupivacaine liposome injectable suspension) for extra indications. He replaces Gary Patou who will remain with the company as a clinical consultant.
Jones has worked on various painkillers, including nonsteroidal anti-inflammatory drugs (NSAIDs), and CNS compounds throughout his career. Previous roles include VP at The Medicines Company, where he was responsible for approval of Ionsys (fentanyl iontophoretic transdermal system). He has also worked as CMO at Cara Therapeutics and is a board-certified emergency medicine doctor.